The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 22, 2025

Filed:

Jun. 20, 2019
Applicant:

Icahn School of Medicine AT Mount Sinai, New York, NY (US);

Inventors:

Adolfo Garcia-Sastre, New York, NY (US);

Peter Palese, New York, NY (US);

Florian Krammer, New York, NY (US);

Felix Bröcker, Berlin, DE;

Weina Sun, New York, NY (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); A61P 31/16 (2006.01); A61P 37/04 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); A61P 31/16 (2018.01); A61P 37/04 (2018.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); G01N 33/5091 (2013.01); C12N 2760/16121 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16123 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16171 (2013.01);
Abstract

In one aspect, provided herein is a mosaic influenza virus hemagglutinin (HA) polypeptide comprising an influenza A virus HA ectodomain of an influenza A virus strain HA, wherein the HA ectodomain comprises an HA stem domain of the influenza A virus strain HA and an HA globular head domain of the influenza A virus strain HA, wherein the HA globular head domain of the influenza A virus strain HA has been engineered to comprise one or more amino acid substitutions in one, two, three, four or all of the antigenic sites. In another aspect, provided herein are immunogenic compositions comprising such a mosaic influenza virus HA polypeptide or an influenza A virus comprising such a mosaic influenza virus HA polypeptide. In yet another aspect, provided herein are methods for immunizing a subject against an influenza A virus in a subject comprising administering such an immunogenic composition to the subject.


Find Patent Forward Citations

Loading…